{"acute pulmonary oedema": 6.89, "allergic transfusion reaction": 221.75, "anaphylactic reaction": 3.6, "anaphylactoid reaction": 2.74, "anti a antibody positive": 334.05, "anti-erythrocyte antibody": 459.23, "anti-erythrocyte antibody positive": 588.79, "autoimmune haemolytic anaemia": 3.96, "back pain": 2.71, "bacteraemia": 2.64, "blood lactate dehydrogenase increased": 3.56, "blood pressure increased": 2.72, "blood pressure systolic increased": 2.4, "body temperature increased": 3.5, "bronchospasm": 4.19, "chills": 2.73, "chromaturia": 2.61, "chronic inflammatory demyelinating polyradiculoneuropathy": 29.09, "coombs direct test positive": 192.13, "cyanosis": 3.48, "delayed haemolytic transfusion reaction": 354.87, "dermatitis allergic": 2.71, "dermatitis exfoliative generalised": 2.33, "device related infection": 3.04, "drug ineffective for unapproved indication": 5.7, "dyshidrotic eczema": 22.26, "dyspnoea": 2.08, "eczema": 4.66, "extravasation": 10.84, "febrile nonhaemolytic transfusion reaction": 288.28, "feeling cold": 2.26, "flank pain": 3.19, "flushing": 5.04, "haemoglobin decreased": 5.45, "haemoglobinuria": 50.43, "haemolysis": 56.99, "haemolytic anaemia": 31.1, "haptoglobin decreased": 36.57, "hepatitis b": 11.71, "hepatitis b core antibody positive": 212.82, "hepatitis b surface antibody positive": 177.08, "hypersensitivity": 3.04, "hypertension": 3.51, "hyperthermia": 7.71, "hypervolaemia": 5.61, "hypotension": 2.81, "hypothermia": 2.53, "hypoxia": 8.56, "incorrect drug administration rate": 34.92, "infusion related reaction": 7.92, "infusion site erythema": 5.77, "infusion site extravasation": 10.25, "infusion site swelling": 8.08, "intravascular haemolysis": 30.75, "kidney infection": 2.28, "livedo reticularis": 17.33, "lung infiltration": 2.77, "meningeal disorder": 51.57, "meningism": 35.7, "meningitis": 6.28, "meningitis aseptic": 167.54, "musculoskeletal stiffness": 3.36, "myasthenia gravis": 2.39, "neck pain": 2.11, "no adverse event": 40.04, "nuchal rigidity": 18.87, "oxygen saturation decreased": 8.81, "phonophobia": 24.24, "photophobia": 8.26, "product use in unapproved indication": 2.52, "recalled product administered": 26.37, "red blood cell spherocytes present": 418.82, "respiratory distress": 3.1, "respiratory rate increased": 14.86, "respiratory tract infection": 2.35, "reticulocyte count increased": 29.55, "sars-cov-2 antibody test positive": 29.67, "sinusitis": 2.59, "skin exfoliation": 3.01, "skin reaction": 2.4, "suspected transmission of an infectious agent via product": 83.45, "tachycardia": 4.06, "tachypnoea": 12.32, "therapy interrupted": 4.22, "throat tightness": 2.69, "toxic skin eruption": 3.67, "transfusion reaction": 74.42, "transfusion-associated dyspnoea": 247.72, "transfusion-related acute lung injury": 111.68, "transfusion-related circulatory overload": 68.98, "troponin increased": 2.45, "unevaluable event": 2.14, "upper respiratory tract infection": 2.16, "urticaria": 2.45, "vomiting": 2.05, "wheezing": 4.54}